ES2485940T3 - Combinación de vacunas contra Meningitis B/C - Google Patents
Combinación de vacunas contra Meningitis B/C Download PDFInfo
- Publication number
- ES2485940T3 ES2485940T3 ES06076647.4T ES06076647T ES2485940T3 ES 2485940 T3 ES2485940 T3 ES 2485940T3 ES 06076647 T ES06076647 T ES 06076647T ES 2485940 T3 ES2485940 T3 ES 2485940T3
- Authority
- ES
- Spain
- Prior art keywords
- combination against
- against meningitis
- vaccination
- vaccination combination
- meningitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Fats And Perfumes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Beans For Foods Or Fodder (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una composición inmunogénica que comprende: i. Un oligosacárido del serogrupo C de Neisseria meningitidis conjugado a una proteína; ii. Una proteína de membrana externa del serogrupo B de Neisseria meningitidis, en la que la proteína de membrana externa se presenta como una vesícula proteoliposomal; y iii. un adyuvante. En la que dicha proteína conjugada al oligosacárido del serogrupo C es CRM197.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8735198P | 1998-05-29 | 1998-05-29 | |
US87351P | 1998-05-29 | ||
US10644698P | 1998-10-30 | 1998-10-30 | |
US106446P | 1998-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2485940T3 true ES2485940T3 (es) | 2014-08-14 |
Family
ID=26776879
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99926046T Expired - Lifetime ES2278446T3 (es) | 1998-05-29 | 1999-05-28 | Vacunas combinadas b/c contra la meningitis. |
ES06076647.4T Expired - Lifetime ES2485940T3 (es) | 1998-05-29 | 1999-05-28 | Combinación de vacunas contra Meningitis B/C |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99926046T Expired - Lifetime ES2278446T3 (es) | 1998-05-29 | 1999-05-28 | Vacunas combinadas b/c contra la meningitis. |
Country Status (15)
Country | Link |
---|---|
US (1) | US8007815B1 (es) |
EP (2) | EP2796148A3 (es) |
JP (2) | JP5074644B2 (es) |
AT (1) | ATE346609T1 (es) |
AU (2) | AU761495B2 (es) |
BR (1) | BR9910749A (es) |
CA (1) | CA2332963C (es) |
CY (1) | CY1107550T1 (es) |
DE (1) | DE69934225T2 (es) |
DK (1) | DK1079857T3 (es) |
ES (2) | ES2278446T3 (es) |
HK (1) | HK1034460A1 (es) |
NZ (1) | NZ508771A (es) |
PT (2) | PT1079857E (es) |
WO (1) | WO1999061053A1 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2266656A1 (en) | 1996-09-17 | 1998-03-26 | Chiron Corporation | Compositions and methods for treating intracellular diseases |
PT1079857E (pt) | 1998-05-29 | 2007-02-28 | Statens Inst For Folkehelse | Combinação de vacinas para a meningite b e c |
NZ528254A (en) | 1999-05-19 | 2005-07-29 | Chiron S | Combined neisserial compositions |
GB9928196D0 (en) * | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
BR0107679A (pt) * | 2000-01-17 | 2004-07-06 | Chiron Spa | Vacina de vesìcula de membrana externa (omv) compreendendo proteìnas de membrana externa do grupo sérico b de neisseria meningitidis |
BRPI0112928B1 (pt) | 2000-07-27 | 2017-08-29 | Children's Hospital & Research Center At Oakland | A composition comprising preparations comprising outer membrane vesicles (OMV), microvesicles (MV) or both MVO and MV |
GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
US20050232936A1 (en) | 2001-07-27 | 2005-10-20 | Chiron Corporation | Meningococcus adhesins nada, app and orf 40 |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
CA2540896C (en) * | 2003-10-02 | 2015-06-02 | Chiron Srl | Liquid vaccines for multiple meningococcal serogroups |
GB0419627D0 (en) | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
NZ555937A (en) | 2005-01-27 | 2009-05-31 | Childrens Hosp & Res Ct Oak | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
BRPI0818545A2 (pt) * | 2007-10-19 | 2017-07-04 | Novartis Ag | formulações de vacinais meningocócicas |
CN104650241A (zh) * | 2009-08-27 | 2015-05-27 | 诺华股份有限公司 | 包括脑膜炎球菌fHBP序列的杂交多肽 |
PL2608805T3 (pl) | 2010-08-23 | 2017-12-29 | Wyeth Llc | Trwałe preparaty antygenów rLP2086 Neisseria meningitidis |
CN103096920B (zh) | 2010-09-10 | 2016-03-23 | 惠氏有限责任公司 | 脑膜炎奈瑟球菌orf2086抗原的非脂质化变体 |
US9259462B2 (en) | 2010-09-10 | 2016-02-16 | Glaxosmithkline Biologicals Sa | Developments in meningococcal outer membrane vesicles |
GB201015132D0 (en) * | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
MY198910A (en) | 2012-03-09 | 2023-10-02 | Pfizer | Neisseria meningitidis compositions and methods thereof |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
MX2015002717A (es) * | 2012-09-06 | 2015-05-15 | Novartis Ag | Vacunas combinadas con meningococo del serogrupo b y toxoides de difteria/tetanos/tosferina. |
CA2882382A1 (en) | 2012-09-18 | 2014-03-27 | Novartis Ag | Outer membrane vesicles |
WO2014136064A2 (en) | 2013-03-08 | 2014-09-12 | Pfizer Inc. | Immunogenic fusion polypeptides |
KR102199096B1 (ko) | 2013-09-08 | 2021-01-06 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
EP3270959A1 (en) | 2015-02-19 | 2018-01-24 | Pfizer Inc | Neisseria meningitidis compositions and methods thereof |
EP3577130A2 (en) | 2017-01-31 | 2019-12-11 | Pfizer Inc | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2848965A1 (de) | 1978-11-11 | 1980-05-22 | Behringwerke Ag | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
US4707543A (en) * | 1985-09-17 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines |
ES2070312T5 (es) | 1988-12-19 | 2003-05-16 | American Cyanamid Co | Vacuna de proteina de membrana exterior meningococica de clase 1. |
US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
EP0624376B1 (en) | 1993-05-13 | 2000-03-15 | American Cyanamid Company | Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci |
ATE173634T1 (de) | 1994-04-20 | 1998-12-15 | Us Army | Impfstoff gegen gram-negative bakterielle infektionen |
US6180111B1 (en) | 1995-05-18 | 2001-01-30 | University Of Maryland | Vaccine delivery system |
ATE261313T1 (de) * | 1995-09-18 | 2004-03-15 | Us Army Medical Res Materiel C | Verbesserte verfahren zur herstellung von nichtkovalent komplexierten und multivalenten impfstoffen gegen proteasomen-untereinheiten |
DE19601754A1 (de) * | 1996-01-19 | 1997-07-24 | Hoechst Ag | Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung |
US5846735A (en) * | 1996-04-18 | 1998-12-08 | University Of Iowa Research Foundation | Hepatitis C virus Fc-binding function |
DE69708318T3 (de) * | 1996-08-27 | 2006-11-16 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung |
US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
EP0994723A1 (en) * | 1997-06-24 | 2000-04-26 | Chiron Corporation | Methods of immunizing adults using anti-meningococcal vaccine compositions |
US6451317B1 (en) * | 1997-07-17 | 2002-09-17 | Baxter International Inc. | Immunogenic conjugates comprising a Group B meningococcal porin and an H influenzae polysaccharide |
GB9727262D0 (en) | 1997-12-24 | 1998-02-25 | Smithkline Beecham Biolog | Vaccine |
PT1079857E (pt) | 1998-05-29 | 2007-02-28 | Statens Inst For Folkehelse | Combinação de vacinas para a meningite b e c |
WO2001034642A2 (en) | 1999-11-12 | 2001-05-17 | University Of Iowa Research Foundation | Control of neisserial membrane synthesis |
BRPI0112928B1 (pt) | 2000-07-27 | 2017-08-29 | Children's Hospital & Research Center At Oakland | A composition comprising preparations comprising outer membrane vesicles (OMV), microvesicles (MV) or both MVO and MV |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
CA2514328C (en) | 2003-01-30 | 2020-01-14 | Chiron Srl | Injectable vaccines against multiple meningococcal serogroups |
GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
CA2540896C (en) | 2003-10-02 | 2015-06-02 | Chiron Srl | Liquid vaccines for multiple meningococcal serogroups |
-
1999
- 1999-05-28 PT PT99926046T patent/PT1079857E/pt unknown
- 1999-05-28 WO PCT/US1999/011977 patent/WO1999061053A1/en active IP Right Grant
- 1999-05-28 JP JP2000550512A patent/JP5074644B2/ja not_active Expired - Fee Related
- 1999-05-28 ES ES99926046T patent/ES2278446T3/es not_active Expired - Lifetime
- 1999-05-28 BR BR9910749-0A patent/BR9910749A/pt not_active Application Discontinuation
- 1999-05-28 AU AU42215/99A patent/AU761495B2/en not_active Revoked
- 1999-05-28 EP EP20140169154 patent/EP2796148A3/en not_active Withdrawn
- 1999-05-28 US US09/701,453 patent/US8007815B1/en not_active Expired - Fee Related
- 1999-05-28 NZ NZ508771A patent/NZ508771A/en not_active IP Right Cessation
- 1999-05-28 AT AT99926046T patent/ATE346609T1/de active
- 1999-05-28 EP EP99926046A patent/EP1079857B1/en not_active Expired - Lifetime
- 1999-05-28 ES ES06076647.4T patent/ES2485940T3/es not_active Expired - Lifetime
- 1999-05-28 PT PT60766474T patent/PT1741443E/pt unknown
- 1999-05-28 CA CA2332963A patent/CA2332963C/en not_active Expired - Fee Related
- 1999-05-28 DE DE69934225T patent/DE69934225T2/de not_active Expired - Lifetime
- 1999-05-28 DK DK99926046T patent/DK1079857T3/da active
-
2001
- 2001-07-20 HK HK01105114A patent/HK1034460A1/xx not_active IP Right Cessation
-
2003
- 2003-09-02 AU AU2003244518A patent/AU2003244518A1/en not_active Withdrawn
-
2007
- 2007-01-31 CY CY20071100128T patent/CY1107550T1/el unknown
-
2009
- 2009-09-24 JP JP2009219818A patent/JP2009292851A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT1741443E (pt) | 2014-07-31 |
DE69934225T2 (de) | 2007-09-27 |
EP1079857A1 (en) | 2001-03-07 |
JP5074644B2 (ja) | 2012-11-14 |
EP1079857B1 (en) | 2006-11-29 |
PT1079857E (pt) | 2007-02-28 |
HK1034460A1 (en) | 2001-10-26 |
WO1999061053A1 (en) | 1999-12-02 |
AU2003244518A1 (en) | 2003-09-25 |
CA2332963A1 (en) | 1999-12-02 |
DE69934225D1 (de) | 2007-01-11 |
DK1079857T3 (da) | 2007-01-29 |
CA2332963C (en) | 2013-07-23 |
NZ508771A (en) | 2003-08-29 |
ATE346609T1 (de) | 2006-12-15 |
AU761495B2 (en) | 2003-06-05 |
CY1107550T1 (el) | 2013-03-13 |
EP2796148A3 (en) | 2015-02-25 |
US8007815B1 (en) | 2011-08-30 |
JP2009292851A (ja) | 2009-12-17 |
EP2796148A2 (en) | 2014-10-29 |
AU4221599A (en) | 1999-12-13 |
ES2278446T3 (es) | 2007-08-01 |
JP2002516292A (ja) | 2002-06-04 |
BR9910749A (pt) | 2001-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2485940T3 (es) | Combinación de vacunas contra Meningitis B/C | |
ES2361993T5 (es) | Tratamiento con enzimas de productos alimenticios para celiaquía | |
LU91778I2 (fr) | Menveo - vaccin méningococcique des groupes A,C, W135 et Y conjugué. | |
KR920019342A (ko) | 골질환 치료제 | |
NO912369D0 (no) | Meningokokk-klasse-1-ytre-membranvaksine. | |
DE60038252D1 (de) | Menschlicher antikörper gegen gangliosid gd3 für die transplantationskomplementarität bestimmente regionund derivate des antikörpers gegen das gangliosid gd3 | |
BR0016022A (pt) | Vacina para a prevenção e tratamento da doença de alzheimer e doenças relacionadas ao amilóide | |
HUP0101017A2 (hu) | Készítmény és eljárás szájon át adagolható vakcinák és gyógyászati hatóanyagok szisztémás bevitelére | |
DE60233401D1 (de) | Medizinisches exzisions- und ultraschall-behandlungssystem | |
AU2001261741A1 (en) | Diagnosis, prevention and treatment of crohn's disease using the ompc antigen | |
ATE347376T1 (de) | Behandlung von allergien | |
HUP0302636A2 (hu) | Hasított burkolt víruskészítmény | |
CY1106092T1 (el) | Χρηση του μακρου μοριου της πεντραξινης ρτχ3 για τη θepαπεια ασθενειων που προκαλουνται απο μια μεταβαλλομενη ενepγοποιηση του αυξητικου παραγοντα fgf-2 | |
FR2720408B1 (fr) | Fragments Tbp2 de Neisseria meningitidis. | |
NO20040611L (no) | Ekspanderbar gastrisk retensjonsanordning. | |
DE69616340D1 (de) | Fungizide mischungen | |
ATE258057T1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
EP1741443A3 (en) | Combination meningitidis B/C vaccines | |
TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
IT236066Y1 (it) | Trasduttore di pressione per linee sangue utilizzate nel trattamentodialitico. | |
SE9902674D0 (sv) | New composition | |
Popowski et al. | Presence of two epiphytic dinoflagellates in two areas of Cancun, Mexico]. | |
RU95108615A (ru) | Минипластинка для устранения посттравматических дефектов и деформаций нижней стенки глазницы | |
ES2127133B1 (es) | Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer. | |
IT1318985B1 (it) | Specola divaricabile per trattamenti idroterapeutici dell'intestino. |